MEDISTIM USA, INC.

Medistim USA, Inc. specializes in the design, manufacturing, and integration of advanced electromedical and surgical instrumentation for clinical and diagnostic applications. Their core capabilities center on high-frequency ultrasound imaging probes, cardiovascular diagnostic systems, and precision flowmeter technologies, demonstrating deep expertise in medical device engineering, signal processing, and FDA-regulated manufacturing. The company’s products, such as the MIRAQ ULTIMATE SYSTEM and L15 ultrasound probe, reflect a focus on real-time hemodynamic monitoring, non-invasive vascular assessment, and integrated diagnostic platforms tailored for interventional and critical care environments. Medistim’s technical differentiation lies in its ability to deliver compact, high-resolution imaging and flow-sensing systems that meet stringent clinical accuracy requirements, with an emphasis on reliability, ease of integration, and compliance with medical device quality standards. The contractor maintains a consistent and focused relationship with the Department of Veterans Affairs, delivering specialized diagnostic and therapeutic equipment for veteran healthcare facilities. Their work supports VA’s mission to modernize clinical workflows through advanced point-of-care technologies, particularly in cardiology, vascular surgery, and perioperative monitoring. Medistim’s primary industry focus is in surgical and medical instrument manufacturing (NAICS 339112), alongside electromedical apparatus production (334510) and surgical appliance manufacturing (339113). This positions them as a niche provider of precision diagnostic tools for procedural and monitoring applications in acute care settings, serving a market that values regulatory compliance, clinical validation, and durable medical hardware. As a small business structured as a 2L entity based in Minneapolis, Minnesota, Medistim USA, Inc. operates without federal certifications but maintains a strong regional footprint in the federal medical technology supply chain. Their market positioning reflects a strategic alignment with VA’s procurement priorities for domestically produced, clinically validated medical devices.